A common gene mutation for Parkinson’s disease drives mislocalization of iron in activated microglia, according to a new study published in the journal PLOS Biology. The results may help explain the accumulation of toxic iron in affected brain areas in the disease and provide a basis for the development of therapies designed to correct the iron trafficking defect.
Mutations in the LRRK2 gene account for about 5% of all cases of familial Parkinson’s disease, and about 1% of non-familial disease cases. LRRK2 is a kinase, an enzyme that regulates other proteins through addition of a phosphate group, and disease-causing mutations are known to increase the kinase activity of the enzyme. One of the targets that LRRK2 regulates is called Rab8a, a protein which, along with many others of the Rab family, helps control the movement or “trafficking” of a wide variety of cellular vesicles (membrane-bound subcellular compartments). One of Rab8a’s jobs is to regulate the import of iron into the cell via the transferrin receptor, and to help recycle that receptor back to the membrane after it releases the transferrin and the iron it carries.
To understand how the LRRK2 mutations found in Parkinson’s disease might affect this process, the authors first visualized Rab8a movements in mouse astrocytes containing LRRK2 with a pathogenic mutation. They found that the mutant protein was responsible for redirecting Rab8a away from its normal location at the endocytic recycling compartment and sequestering it at damaged lysosomes.
This mislocalization of Rab8a had a clear effect on the transferrin receptor: in cells containing normal LRRK2, the transferrin receptor was distributed among multiple vesicle types. However, in cells containing the Parkinson’s mutant LRRK2, the transferrin receptor and its iron instead clustered at the same damaged lysosomes where Rab8a and mutant LRRK2 were found. That same mislocalization of Rab8a and transferrin receptors was observed in activated microglia derived from human cells carrying a pathogenic LRRK2 mutation. Microglia are key drivers of inflammation in the brain. Finally, when mice carrying the same Parkinson’s mutation were exposed to a proinflammatory trigger, iron accumulated in microglia in the striatum, a region of the brain that controls movement and is one of the most prominent parts of the brain affected in Parkinson’s disease.
“Our data suggest that a key step in the pathogenesis of LRRK2 Parkinson’s disease is the interaction of the protein with Rab8a and its subsequent effect on mislocalization of iron in activated microglia,” the senior author said. Iron deposition in the brain is a feature of Parkinson’s disease and other neurodegenerative diseases, and its accumulation may drive free radical production and damage to mitochondria, both thought to be critical steps in the disease cascade. “These results should help us understand the implications of blocking LRRK2 as a potential therapeutic for Parkinson’s disease.”
“Our study demonstrates altered regulation of iron in Parkinson's disease models based on the gene LRRK2,” the author adds. “Previous data has shown that iron can be deposited in the brain, which we now link to a known genetic cause of Parkinson’s disease that may be relevant to novel treatments.”
https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3001480
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fmutations-in-lrrk2&filter=22
Iron trafficking is misdirected by LRRK2 mutation in Parkinson's
- 1,404 views
- Added
Latest News
Protein that helps COVID-19…
By newseditor
Posted 26 Jul
Spinal Muscular Atrophy (SM…
By newseditor
Posted 26 Jul
Link between bowel movement…
By newseditor
Posted 26 Jul
Inhibition of IL-11 signall…
By newseditor
Posted 25 Jul
Brain changes linked to obe…
By newseditor
Posted 25 Jul
Other Top Stories
Alternate splicing sequence determinants identified!
Read more
MicroRNAs regulating cholesterol and triglyceride homeostasis ident…
Read more
RNA Controls Poly-glutamine Protein Phase Transitions
Read more
Nuclear membrane repairs the 'dark matter' of DNA
Read more
Transmembrane protein sorting driven by membrane curvature
Read more
Protocols
A systems biology approach…
By newseditor
Posted 24 Jul
quantms: a cloud-based pipe…
By newseditor
Posted 22 Jul
Emerging tools and best pra…
By newseditor
Posted 19 Jul
Directly selecting cell-typ…
By newseditor
Posted 17 Jul
PUFFFIN: an ultra-bright, c…
By newseditor
Posted 16 Jul
Publications
Hepatocyte-intrinsic SMN de…
By newseditor
Posted 26 Jul
Aberrant bowel movement fre…
By newseditor
Posted 26 Jul
A pseudoautosomal glycosyla…
By newseditor
Posted 26 Jul
Microglia protect against a…
By newseditor
Posted 26 Jul
Rigor and reproducibility i…
By newseditor
Posted 26 Jul
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar